Global Antimicrobial Efficacy Testing Market Research Report 2023

Publication ID:

PB510238895

Publication Date:

October 25, 2023

Pages:

112

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Efficacy Testing is a set of procedures in product research and development that are conducted to test the product鈥檚 intended purpose in order to substantiate those all-important claims that appear on your packaging or in your advertisements.
The global Antimicrobial Efficacy Testing market is projected to reach US$ 396.3 million in 2029, increasing from US$ 296.7 million in 2022, with the CAGR of 3.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antimicrobial Efficacy Testing 91制片厂.
The Antimicrobial Efficacy Testing market was experiencing growth due to increasing concerns about antimicrobial resistance, infection control, and the need to ensure the effectiveness of antimicrobial products and treatments. Antimicrobial efficacy testing involves assessing the ability of antimicrobial agents to inhibit or kill microorganisms such as bacteria, viruses, and fungi.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antimicrobial Efficacy Testing market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Charles River Laboratories
WuXi AppTec
Eurofins Scientific
SGS
Intertek Group
Nelson Laboratories
Microbac Laboratories
Almac Group
North American Science Associates
Toxikon
Pacific Biolabs
MSL Solution Providers
Accugen Laboratories
Consumer Product Testing Company
Lucideon
BioScience Laboratories
ALS Limited
Microchem Laboratory
Oxford Biosciences Ltd.
Abbott Analytical
Helvic Laboratories
Honeyman Group Limited
Danish Technological Institute
BluTest Laboratories Limited
Segment by Type
Preservative Efficacy Testing
Disinfectant Efficacy Testing
Segment by Application
Pharmaceutical Manufacturing
Cosmetics and Personal Care Product
Medical Device
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Antimicrobial Efficacy Testing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Antimicrobial Efficacy Testing Market Overview
1.1 Product Overview and Scope of Antimicrobial Efficacy Testing
1.2 Antimicrobial Efficacy Testing Segment by Type
1.2.1 Global Antimicrobial Efficacy Testing Market Value Comparison by Type (2023-2029)
1.2.2 Preservative Efficacy Testing
1.2.3 Disinfectant Efficacy Testing
1.3 Antimicrobial Efficacy Testing Segment by Application
1.3.1 Global Antimicrobial Efficacy Testing Market Value by Application: (2023-2029)
1.3.2 Pharmaceutical Manufacturing
1.3.3 Cosmetics and Personal Care Product
1.3.4 Medical Device
1.3.5 Others
1.4 Global Antimicrobial Efficacy Testing Market Size Estimates and Forecasts
1.4.1 Global Antimicrobial Efficacy Testing Revenue 2018-2029
1.4.2 Global Antimicrobial Efficacy Testing Sales 2018-2029
1.4.3 Global Antimicrobial Efficacy Testing Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Antimicrobial Efficacy Testing Market Competition by Manufacturers
2.1 Global Antimicrobial Efficacy Testing Sales Market Share by Manufacturers (2018-2023)
2.2 Global Antimicrobial Efficacy Testing Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Antimicrobial Efficacy Testing Average Price by Manufacturers (2018-2023)
2.4 Global Antimicrobial Efficacy Testing Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Antimicrobial Efficacy Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antimicrobial Efficacy Testing, Product Type & Application
2.7 Antimicrobial Efficacy Testing Market Competitive Situation and Trends
2.7.1 Antimicrobial Efficacy Testing Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antimicrobial Efficacy Testing Players Market Share by Revenue
2.7.3 Global Antimicrobial Efficacy Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antimicrobial Efficacy Testing Retrospective Market Scenario by Region
3.1 Global Antimicrobial Efficacy Testing Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Antimicrobial Efficacy Testing Global Antimicrobial Efficacy Testing Sales by Region: 2018-2029
3.2.1 Global Antimicrobial Efficacy Testing Sales by Region: 2018-2023
3.2.2 Global Antimicrobial Efficacy Testing Sales by Region: 2024-2029
3.3 Global Antimicrobial Efficacy Testing Global Antimicrobial Efficacy Testing Revenue by Region: 2018-2029
3.3.1 Global Antimicrobial Efficacy Testing Revenue by Region: 2018-2023
3.3.2 Global Antimicrobial Efficacy Testing Revenue by Region: 2024-2029
3.4 North America Antimicrobial Efficacy Testing Market Facts & Figures by Country
3.4.1 North America Antimicrobial Efficacy Testing Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Antimicrobial Efficacy Testing Sales by Country (2018-2029)
3.4.3 North America Antimicrobial Efficacy Testing Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antimicrobial Efficacy Testing Market Facts & Figures by Country
3.5.1 Europe Antimicrobial Efficacy Testing Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Antimicrobial Efficacy Testing Sales by Country (2018-2029)
3.5.3 Europe Antimicrobial Efficacy Testing Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antimicrobial Efficacy Testing Market Facts & Figures by Country
3.6.1 Asia Pacific Antimicrobial Efficacy Testing Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Antimicrobial Efficacy Testing Sales by Country (2018-2029)
3.6.3 Asia Pacific Antimicrobial Efficacy Testing Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antimicrobial Efficacy Testing Market Facts & Figures by Country
3.7.1 Latin America Antimicrobial Efficacy Testing Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Antimicrobial Efficacy Testing Sales by Country (2018-2029)
3.7.3 Latin America Antimicrobial Efficacy Testing Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antimicrobial Efficacy Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Antimicrobial Efficacy Testing Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Antimicrobial Efficacy Testing Sales by Country (2018-2029)
3.8.3 Middle East and Africa Antimicrobial Efficacy Testing Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antimicrobial Efficacy Testing Sales by Type (2018-2029)
4.1.1 Global Antimicrobial Efficacy Testing Sales by Type (2018-2023)
4.1.2 Global Antimicrobial Efficacy Testing Sales by Type (2024-2029)
4.1.3 Global Antimicrobial Efficacy Testing Sales Market Share by Type (2018-2029)
4.2 Global Antimicrobial Efficacy Testing Revenue by Type (2018-2029)
4.2.1 Global Antimicrobial Efficacy Testing Revenue by Type (2018-2023)
4.2.2 Global Antimicrobial Efficacy Testing Revenue by Type (2024-2029)
4.2.3 Global Antimicrobial Efficacy Testing Revenue Market Share by Type (2018-2029)
4.3 Global Antimicrobial Efficacy Testing Price by Type (2018-2029)
5 Segment by Application
5.1 Global Antimicrobial Efficacy Testing Sales by Application (2018-2029)
5.1.1 Global Antimicrobial Efficacy Testing Sales by Application (2018-2023)
5.1.2 Global Antimicrobial Efficacy Testing Sales by Application (2024-2029)
5.1.3 Global Antimicrobial Efficacy Testing Sales Market Share by Application (2018-2029)
5.2 Global Antimicrobial Efficacy Testing Revenue by Application (2018-2029)
5.2.1 Global Antimicrobial Efficacy Testing Revenue by Application (2018-2023)
5.2.2 Global Antimicrobial Efficacy Testing Revenue by Application (2024-2029)
5.2.3 Global Antimicrobial Efficacy Testing Revenue Market Share by Application (2018-2029)
5.3 Global Antimicrobial Efficacy Testing Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Charles River Laboratories
6.1.1 Charles River Laboratories Corporation Information
6.1.2 Charles River Laboratories Description and Business Overview
6.1.3 Charles River Laboratories Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Charles River Laboratories Antimicrobial Efficacy Testing Product Portfolio
6.1.5 Charles River Laboratories Recent Developments/Updates
6.2 WuXi AppTec
6.2.1 WuXi AppTec Corporation Information
6.2.2 WuXi AppTec Description and Business Overview
6.2.3 WuXi AppTec Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.2.4 WuXi AppTec Antimicrobial Efficacy Testing Product Portfolio
6.2.5 WuXi AppTec Recent Developments/Updates
6.3 Eurofins Scientific
6.3.1 Eurofins Scientific Corporation Information
6.3.2 Eurofins Scientific Description and Business Overview
6.3.3 Eurofins Scientific Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eurofins Scientific Antimicrobial Efficacy Testing Product Portfolio
6.3.5 Eurofins Scientific Recent Developments/Updates
6.4 SGS
6.4.1 SGS Corporation Information
6.4.2 SGS Description and Business Overview
6.4.3 SGS Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.4.4 SGS Antimicrobial Efficacy Testing Product Portfolio
6.4.5 SGS Recent Developments/Updates
6.5 Intertek Group
6.5.1 Intertek Group Corporation Information
6.5.2 Intertek Group Description and Business Overview
6.5.3 Intertek Group Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Intertek Group Antimicrobial Efficacy Testing Product Portfolio
6.5.5 Intertek Group Recent Developments/Updates
6.6 Nelson Laboratories
6.6.1 Nelson Laboratories Corporation Information
6.6.2 Nelson Laboratories Description and Business Overview
6.6.3 Nelson Laboratories Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Nelson Laboratories Antimicrobial Efficacy Testing Product Portfolio
6.6.5 Nelson Laboratories Recent Developments/Updates
6.7 Microbac Laboratories
6.6.1 Microbac Laboratories Corporation Information
6.6.2 Microbac Laboratories Description and Business Overview
6.6.3 Microbac Laboratories Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Microbac Laboratories Antimicrobial Efficacy Testing Product Portfolio
6.7.5 Microbac Laboratories Recent Developments/Updates
6.8 Almac Group
6.8.1 Almac Group Corporation Information
6.8.2 Almac Group Description and Business Overview
6.8.3 Almac Group Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Almac Group Antimicrobial Efficacy Testing Product Portfolio
6.8.5 Almac Group Recent Developments/Updates
6.9 North American Science Associates
6.9.1 North American Science Associates Corporation Information
6.9.2 North American Science Associates Description and Business Overview
6.9.3 North American Science Associates Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.9.4 North American Science Associates Antimicrobial Efficacy Testing Product Portfolio
6.9.5 North American Science Associates Recent Developments/Updates
6.10 Toxikon
6.10.1 Toxikon Corporation Information
6.10.2 Toxikon Description and Business Overview
6.10.3 Toxikon Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Toxikon Antimicrobial Efficacy Testing Product Portfolio
6.10.5 Toxikon Recent Developments/Updates
6.11 Pacific Biolabs
6.11.1 Pacific Biolabs Corporation Information
6.11.2 Pacific Biolabs Antimicrobial Efficacy Testing Description and Business Overview
6.11.3 Pacific Biolabs Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Pacific Biolabs Antimicrobial Efficacy Testing Product Portfolio
6.11.5 Pacific Biolabs Recent Developments/Updates
6.12 MSL Solution Providers
6.12.1 MSL Solution Providers Corporation Information
6.12.2 MSL Solution Providers Antimicrobial Efficacy Testing Description and Business Overview
6.12.3 MSL Solution Providers Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.12.4 MSL Solution Providers Antimicrobial Efficacy Testing Product Portfolio
6.12.5 MSL Solution Providers Recent Developments/Updates
6.13 Accugen Laboratories
6.13.1 Accugen Laboratories Corporation Information
6.13.2 Accugen Laboratories Antimicrobial Efficacy Testing Description and Business Overview
6.13.3 Accugen Laboratories Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Accugen Laboratories Antimicrobial Efficacy Testing Product Portfolio
6.13.5 Accugen Laboratories Recent Developments/Updates
6.14 Consumer Product Testing Company
6.14.1 Consumer Product Testing Company Corporation Information
6.14.2 Consumer Product Testing Company Antimicrobial Efficacy Testing Description and Business Overview
6.14.3 Consumer Product Testing Company Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Consumer Product Testing Company Antimicrobial Efficacy Testing Product Portfolio
6.14.5 Consumer Product Testing Company Recent Developments/Updates
6.15 Lucideon
6.15.1 Lucideon Corporation Information
6.15.2 Lucideon Antimicrobial Efficacy Testing Description and Business Overview
6.15.3 Lucideon Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Lucideon Antimicrobial Efficacy Testing Product Portfolio
6.15.5 Lucideon Recent Developments/Updates
6.16 BioScience Laboratories
6.16.1 BioScience Laboratories Corporation Information
6.16.2 BioScience Laboratories Antimicrobial Efficacy Testing Description and Business Overview
6.16.3 BioScience Laboratories Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.16.4 BioScience Laboratories Antimicrobial Efficacy Testing Product Portfolio
6.16.5 BioScience Laboratories Recent Developments/Updates
6.17 ALS Limited
6.17.1 ALS Limited Corporation Information
6.17.2 ALS Limited Antimicrobial Efficacy Testing Description and Business Overview
6.17.3 ALS Limited Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.17.4 ALS Limited Antimicrobial Efficacy Testing Product Portfolio
6.17.5 ALS Limited Recent Developments/Updates
6.18 Microchem Laboratory
6.18.1 Microchem Laboratory Corporation Information
6.18.2 Microchem Laboratory Antimicrobial Efficacy Testing Description and Business Overview
6.18.3 Microchem Laboratory Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Microchem Laboratory Antimicrobial Efficacy Testing Product Portfolio
6.18.5 Microchem Laboratory Recent Developments/Updates
6.19 Oxford Biosciences Ltd.
6.19.1 Oxford Biosciences Ltd. Corporation Information
6.19.2 Oxford Biosciences Ltd. Antimicrobial Efficacy Testing Description and Business Overview
6.19.3 Oxford Biosciences Ltd. Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Oxford Biosciences Ltd. Antimicrobial Efficacy Testing Product Portfolio
6.19.5 Oxford Biosciences Ltd. Recent Developments/Updates
6.20 Abbott Analytical
6.20.1 Abbott Analytical Corporation Information
6.20.2 Abbott Analytical Antimicrobial Efficacy Testing Description and Business Overview
6.20.3 Abbott Analytical Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Abbott Analytical Antimicrobial Efficacy Testing Product Portfolio
6.20.5 Abbott Analytical Recent Developments/Updates
6.21 Helvic Laboratories
6.21.1 Helvic Laboratories Corporation Information
6.21.2 Helvic Laboratories Antimicrobial Efficacy Testing Description and Business Overview
6.21.3 Helvic Laboratories Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Helvic Laboratories Antimicrobial Efficacy Testing Product Portfolio
6.21.5 Helvic Laboratories Recent Developments/Updates
6.22 Honeyman Group Limited
6.22.1 Honeyman Group Limited Corporation Information
6.22.2 Honeyman Group Limited Antimicrobial Efficacy Testing Description and Business Overview
6.22.3 Honeyman Group Limited Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Honeyman Group Limited Antimicrobial Efficacy Testing Product Portfolio
6.22.5 Honeyman Group Limited Recent Developments/Updates
6.23 Danish Technological Institute
6.23.1 Danish Technological Institute Corporation Information
6.23.2 Danish Technological Institute Antimicrobial Efficacy Testing Description and Business Overview
6.23.3 Danish Technological Institute Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Danish Technological Institute Antimicrobial Efficacy Testing Product Portfolio
6.23.5 Danish Technological Institute Recent Developments/Updates
6.24 BluTest Laboratories Limited
6.24.1 BluTest Laboratories Limited Corporation Information
6.24.2 BluTest Laboratories Limited Antimicrobial Efficacy Testing Description and Business Overview
6.24.3 BluTest Laboratories Limited Antimicrobial Efficacy Testing Sales, Revenue and Gross Margin (2018-2023)
6.24.4 BluTest Laboratories Limited Antimicrobial Efficacy Testing Product Portfolio
6.24.5 BluTest Laboratories Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antimicrobial Efficacy Testing Industry Chain Analysis
7.2 Antimicrobial Efficacy Testing Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antimicrobial Efficacy Testing Production Mode & Process
7.4 Antimicrobial Efficacy Testing Sales and Marketing
7.4.1 Antimicrobial Efficacy Testing Sales Channels
7.4.2 Antimicrobial Efficacy Testing Distributors
7.5 Antimicrobial Efficacy Testing Customers
8 Antimicrobial Efficacy Testing Market Dynamics
8.1 Antimicrobial Efficacy Testing Industry Trends
8.2 Antimicrobial Efficacy Testing Market Drivers
8.3 Antimicrobial Efficacy Testing Market Challenges
8.4 Antimicrobial Efficacy Testing Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Charles River Laboratories
WuXi AppTec
Eurofins Scientific
SGS
Intertek Group
Nelson Laboratories
Microbac Laboratories
Almac Group
North American Science Associates
Toxikon
Pacific Biolabs
MSL Solution Providers
Accugen Laboratories
Consumer Product Testing Company
Lucideon
BioScience Laboratories
ALS Limited
Microchem Laboratory
Oxford Biosciences Ltd.
Abbott Analytical
Helvic Laboratories
Honeyman Group Limited
Danish Technological Institute
BluTest Laboratories Limited

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.